Successful treatment of heart failure due to acute transplant rejection with the Impella LP 5.0.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19559242.
- Also identified by DOI 10.1016/j.athoracsur.2008.12.036.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cardiogenic shock resulting from transplant rejection is a serious complication with high mortality and morbidity. Often resistant to maximal medical therapy, this condition frequently requires mechanical circulatory support until recovery or retransplantation. We present a 52-year-old patient with multiorgan failure secondary to acute graft rejection after orthotopic heart transplantation. Maximal medical therapy was not successful, and the patient was bridged to recovery with an Impella LP 5.0 (Abiomed Inc, Danvers, MA) left ventricular assist device (LVAD). The relative merits of this therapeutic approach are outlined and discussed. The patient was discharged 3 weeks after LVAD removal and remains clinically stable.
Medical subject headings
- Graft Rejection
- Heart Failure
- Heart Transplantation
- Heart-Assist Devices
- Shock, Cardiogenic